BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu CJ, Lo SC, Kao JH, Tseng PT, Lai MY, Ni YH, Yeh SH, Chen PJ, Chen DS. Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan. J Hepatol. 2006;44:39-46. [PMID: 16168517 DOI: 10.1016/j.jhep.2005.06.016] [Cited by in Crossref: 81] [Cited by in F6Publishing: 76] [Article Influence: 5.1] [Reference Citation Analysis]
Number Citing Articles
1 Mulrooney-Cousins PM, Michalak TI. Repeated passage of wild-type woodchuck hepatitis virus in lymphoid cells does not generate cell type-specific variants or alter virus infectivity. J Virol 2008;82:7540-50. [PMID: 18495768 DOI: 10.1128/JVI.00405-08] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
2 Blackard JT, Martin CM, Sengupta S, Forrester J. Limited infection with occult hepatitis B virus in drug users in the USA. Hepatol Res 2013;43:413-7. [PMID: 22909008 DOI: 10.1111/j.1872-034X.2012.01072.x] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
3 Kramvis A. The clinical implications of hepatitis B virus genotypes and HBeAg in pediatrics. Rev Med Virol 2016;26:285-303. [PMID: 27139263 DOI: 10.1002/rmv.1885] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 7.0] [Reference Citation Analysis]
4 Said ZNA. An overview of occult hepatitis B virus infection. World J Gastroenterol 2011; 17(15): 1927-1938 [PMID: 21528070 DOI: 10.3748/wjg.v17.i15.1927] [Cited by in CrossRef: 98] [Cited by in F6Publishing: 84] [Article Influence: 9.8] [Reference Citation Analysis]
5 Lledó JL, Fernández C, Gutiérrez ML, Ocaña S. Management of occult hepatitis B virus infection: An update for the clinician. World J Gastroenterol 2011; 17(12): 1563-1568 [PMID: 21472122 DOI: 10.3748/wjg.v17.i12.1563] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
6 Lin KT, Chang CL, Tsai MH, Lin KS, Saldanha J, Hung CM. Detection and identification of occult HBV in blood donors in Taiwan using a commercial, multiplex, multi-dye nucleic acid amplification technology screening test. Vox Sang. 2014;106:103-110. [PMID: 23909571 DOI: 10.1111/vox.12075] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
7 Ohhashi Y, Pai A, Halait H, Ziermann R. Analytical and clinical performance evaluation of the cobas TaqScreen MPX Test for use on the cobas s 201 system. Journal of Virological Methods 2010;165:246-53. [DOI: 10.1016/j.jviromet.2010.02.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
8 Liu C, Chen D, Chen P. Epidemiology of HBV infection in Asian blood donors: Emphasis on occult HBV infection and the role of NAT. Journal of Clinical Virology 2006;36:S33-44. [DOI: 10.1016/s1386-6532(06)80007-7] [Cited by in Crossref: 72] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
9 Candotti D, Allain JP. Transfusion-transmitted hepatitis B virus infection. J Hepatol. 2009;51:798-809. [PMID: 19615780 DOI: 10.1016/j.jhep.2009.05.020] [Cited by in Crossref: 115] [Cited by in F6Publishing: 122] [Article Influence: 9.6] [Reference Citation Analysis]
10 Ni YH. Natural history of hepatitis B virus infection: pediatric perspective. J Gastroenterol. 2011;46:1-8. [PMID: 20812021 DOI: 10.1007/s00535-010-0304-7] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 3.6] [Reference Citation Analysis]
11 Seed CR, Jones NT, Pickworth AM, Graham WR. Two cases of asymptomatic HBV "vaccine breakthrough" infection detected in blood donors screened for HBV DNA. Med J Aust 2012;196:651-2. [PMID: 22676882 DOI: 10.5694/mja11.11589] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
12 Xiao X, Zhai J, Zeng J, Tian C, Wu H, Yu Y. Comparative evaluation of a triplex nucleic acid test for detection of HBV DNA, HCV RNA, and HIV-1 RNA, with the Procleix Tigris System. Journal of Virological Methods 2013;187:357-61. [DOI: 10.1016/j.jviromet.2012.10.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
13 Bihl F, Castelli D, Marincola F, Dodd RY, Brander C. Transfusion-transmitted infections. J Transl Med. 2007;5:25. [PMID: 17553144 DOI: 10.1186/1479-5876-5-25] [Cited by in Crossref: 96] [Cited by in F6Publishing: 82] [Article Influence: 6.9] [Reference Citation Analysis]
14 Zobeiri M. Occult hepatitis B: clinical viewpoint and management. Hepat Res Treat. 2013;2013:259148. [PMID: 23533738 DOI: 10.1155/2013/259148] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
15 Said ZN, El-Sayed MH, El-Bishbishi IA, El-Fouhil DF, Abdel-Rheem SE, El-Abedin MZ, Salama , II . High prevalence of occult hepatitis B in hepatitis C-infected Egyptian children with haematological disorders and malignancies. Liver Int. 2009;29:518-524. [PMID: 19192168 DOI: 10.1111/j.1478-3231.2009.01975.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
16 Anderson M, Choga WT, Moyo S, Bell TG, Mbangiwa T, Phinius BB, Bhebhe L, Sebunya TK, Lockman S, Marlink R, Kramvis A, Essex M, Musonda RM, Blackard JT, Gaseitsiwe S. Molecular Characterization of Near Full-Length Genomes of Hepatitis B Virus Isolated from Predominantly HIV Infected Individuals in Botswana. Genes (Basel) 2018;9:E453. [PMID: 30205537 DOI: 10.3390/genes9090453] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
17 Hung WL, Wu JF, Ni YH, Chen HL, Chiang CL, Chang MH, Hsu HY. Occult hepatitis B virus and surface antigen mutant infection in healthy vaccinated cohorts and children with various forms of hepatitis and multiple transfusions. Liver Int 2019;39:1052-61. [PMID: 30790411 DOI: 10.1111/liv.14076] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
18 Jang SY, Kim MS, Park MS, Lee KM, Chung HW, Chun J, Lee CH. Designing primers from multiple sequences using Matchup program to improve detection of hepatitis B virus by polymerase chain reaction. J Microbiol 2010;48:111-6. [PMID: 20221738 DOI: 10.1007/s12275-009-0282-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
19 Lin C, Liu C, Chen P, Lai M, Chen D, Kao J. High prevalence of occult hepatitis B virus infection in Taiwanese intravenous drug users. J Med Virol 2007;79:1674-8. [DOI: 10.1002/jmv.20985] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
20 Xie M, Rao W, Yang T, Deng Y, Zheng H, Pan C, Liu Y, Shen Z, Jia J. Occult hepatitis B virus infection predicts de novo hepatitis B infection in patients with alcoholic cirrhosis after liver transplantation. Liver Int. 2015;35:897-904. [PMID: 24750566 DOI: 10.1111/liv.12567] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
21 Hoda K, Nguyen MH. Chronic hepatitis B virus infection in patients with “Normal” ALT levels. Current Hepatitis Reports 2007;6:24-9. [DOI: 10.1007/bf02942175] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
22 Azarkar Z, Ziaee M, Ebrahimzadeh A, Sharifzadeh G, Javanmard D. Epidemiology, risk factors, and molecular characterization of occult hepatitis B infection among anti-hepatitis B core antigen alone subjects. J Med Virol 2019;91:615-22. [PMID: 30345529 DOI: 10.1002/jmv.25343] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Sohn Y, Oh H, Ko S, Lim Y, Kwon O. Analysis of Clinical Characteristics and S Gene Mutation of Hepatitis B Virus (HBV) in Patients with Hepatitis B Surface Antigen RIA Negative and HBV DNA Positive. Ann Lab Med 2009;29:224-30. [DOI: 10.3343/kjlm.2009.29.3.224] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
24 Linauts S, Saldanha J, Strong DM. PRISM hepatitis B surface antigen detection of hepatits B virus minipool nucleic acid testing yield samples. Transfusion. 2008;48:1376-1382. [PMID: 18422847 DOI: 10.1111/j.1537-2995.2008.01698.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
25 Ni YH, Chang MH, Jan CF, Hsu HY, Chen HL, Wu JF, Chen DS. Continuing Decrease in Hepatitis B Virus Infection 30 Years After Initiation of Infant Vaccination Program in Taiwan. Clin Gastroenterol Hepatol. 2016;14:1324-1330. [PMID: 27155556 DOI: 10.1016/j.cgh.2016.04.030] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 9.4] [Reference Citation Analysis]
26 Komatsu H, Klenerman P, Thimme R. Discordance of hepatitis B vaccination policies for healthcare workers between the USA, the UK, and Germany. Hepatol Res 2020;50:272-82. [DOI: 10.1111/hepr.13470] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
27 Motta-castro ARC, Martins RMB, Araujo NM, Niel C, Facholi GB, Lago BV, Mello FCA, Gomes SA. Molecular epidemiology of hepatitis B virus in an isolated Afro-Brazilian community. Arch Virol 2008;153:2197-205. [DOI: 10.1007/s00705-008-0237-0] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 3.0] [Reference Citation Analysis]
28 Su WJ, Ho MC, Ni YH, Chen HL, Hu RH, Wu YM, Chang MH, Lee PH. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection. J Pediatr Gastroenterol Nutr. 2009;48:203-208. [PMID: 19179883 DOI: 10.1097/mpg.0b013e3181819ad4] [Cited by in Crossref: 37] [Cited by in F6Publishing: 8] [Article Influence: 3.1] [Reference Citation Analysis]
29 Hsu EK, Murray KF. Hepatitis B and C in children. Nat Rev Gastroenterol Hepatol 2008;5:311-20. [DOI: 10.1038/ncpgasthep1124] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
30 Mulrooney-Cousins PM, Michalak TI. Persistent occult hepatitis B virus infection: Experimental findings and clinical implications. World J Gastroenterol 2007; 13(43): 5682-5686 [PMID: 17963292 DOI: 10.3748/wjg.v13.i43.5682] [Cited by in CrossRef: 48] [Cited by in F6Publishing: 47] [Article Influence: 3.4] [Reference Citation Analysis]
31 Yang MH, Li L, Hung YS, Hung CS, Allain JP, Lin KS, Tsai SJ. The efficacy of individual-donation and minipool testing to detect low-level hepatitis B virus DNA in Taiwan. Transfusion. 2010;50:65-74. [PMID: 19709394 DOI: 10.1111/j.1537-2995.2009.02357.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
32 Kwak MS, Kim YJ. Occult hepatitis B virus infection. World J Hepatol 2014; 6(12): 860-869 [PMID: 25544873 DOI: 10.4254/wjh.v6.i12.860] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 6.6] [Reference Citation Analysis]
33 Dettori S, Candido A, Kondili LA, Chionne P, Taffon S, Genovese D, Iudicone P, Miceli M, Rapicetta M. Identification of low HBV-DNA levels by nucleic acid amplification test (NAT) in blood donors. J Infect. 2009;59:128-133. [PMID: 19586663 DOI: 10.1016/j.jinf.2009.06.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
34 Hsu H, Chang M, Ni Y, Chiang C, Wu J, Chen H, Chen P, Chen D. Chronologic changes in serum hepatitis B virus DNA, genotypes, surface antigen mutants and reverse transcriptase mutants during 25-year nationwide immunization in Taiwan. J Viral Hepat 2017;24:645-53. [DOI: 10.1111/jvh.12687] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
35 Olotu AA, Oyelese AO, Salawu L, Audu RA, Okwuraiwe AP, Aboderin AO. Occult Hepatitis B virus infection in previously screened, blood donors in Ile-Ife, Nigeria: implications for blood transfusion and stem cell transplantation. Virol J 2016;13:76. [PMID: 27150469 DOI: 10.1186/s12985-016-0533-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
36 Wang HH, Sun SL, Jau RC, Tantoh DM, Hsu SY, Nfor ON, Chen PH, Liu WH, Ko JL, Liaw YP. Risk of HBV infection among male and female first-time blood donors born before and after the July 1986 HBV vaccination program in Taiwan. BMC Public Health 2021;21:1831. [PMID: 34627173 DOI: 10.1186/s12889-021-11846-x] [Reference Citation Analysis]
37 Dong C, Gao W, Ma N, Sun C, Zheng WP, Wang K, Shen ZY. Risks and treatment strategies for de novo hepatitis B virus infection from anti-HBc-positive donors in pediatric living donor liver transplantation. Pediatr Transplant. 2017;21. [PMID: 27933716 DOI: 10.1111/petr.12854] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
38 Su TH, Chen PJ, Chen TC, Cheng HR, Li L, Lin KS, Kao JH, Chen DS, Liu CJ. The clinical significance of occult hepatitis B transfusion in Taiwan--a look-back study. Transfus Med. 2011;21:33-41. [PMID: 20726954 DOI: 10.1111/j.1365-3148.2010.01036.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
39 Urbani S, Fagnoni F, Missale G, Franchini M. The role of anti-core antibody response in the detection of occult hepatitis B virus infection. Clin Chem Lab Med. 2010;48:23-29. [PMID: 19919328 DOI: 10.1515/cclm.2010.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
40 Ni YH, Chang MH, Wu JF, Hsu HY, Chen HL, Chen DS. Minimization of hepatitis B infection by a 25-year universal vaccination program. J Hepatol. 2012;57:730-735. [PMID: 22668640 DOI: 10.1016/j.jhep.2012.05.021] [Cited by in Crossref: 133] [Cited by in F6Publishing: 122] [Article Influence: 14.8] [Reference Citation Analysis]
41 Franz C, Perez Rde M, Zalis MG, Zalona AC, Rocha PT, Gonçalves RT, Nabuco LC, Villela-Nogueira CA. Prevalence of occult hepatitis B virus infection in kidney transplant recipients. Mem Inst Oswaldo Cruz. 2013;108:657-660. [PMID: 23903984 DOI: 10.1590/0074-0276108052013019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
42 Louisirirotchanakul S, Oota S, Khuponsarb K, Chalermchan W, Phikulsod S, Chongkolwatana V, Sakuldamrongpanish T, Kitpoka P, Chielsilp P, Tanprasert S, Tirawatnapong T, Wasi C; Working Group for NAT Study in Thai Blood Donations. Occult hepatitis B virus infection in Thai blood donors. Transfusion 2011;51:1532-40. [PMID: 21251005 DOI: 10.1111/j.1537-2995.2010.03023.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
43 Taira R, Satake M, Momose S, Hino S, Suzuki Y, Murokawa H, Uchida S, Tadokoro K. Residual risk of transfusion-transmitted hepatitis B virus (HBV) infection caused by blood components derived from donors with occult HBV infection in Japan. Transfusion. 2013;53:1393-1404. [PMID: 23033944 DOI: 10.1111/j.1537-2995.2012.03909.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 53] [Article Influence: 6.8] [Reference Citation Analysis]
44 Bouchardeau F, Girault A, Razer A, Servant-Delmas A, Mercier M, Laperche S. Sensitivity of hepatitis B virus DNA transcription-mediated amplification testing in hepatitis B surface antigen-positive blood donations. Transfusion 2006;46:2047-52. [PMID: 17176315 DOI: 10.1111/j.1537-2995.2006.01031.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
45 Arababadi MK, Hassanshahi G, Pourfathollah AA, Zarandi ER, Kennedy D. Post-transfusion occult hepatitis B (OBI): a global challenge for blood recipients and health authorities. Hepat Mon. 2011;11:714-718. [PMID: 22235213 DOI: 10.5812/kowsar.1735143x.694] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
46 Lai MW, Lin TY, Liang KH, Lin WR, Yeh CT. Hepatitis B viremia in completely immunized individuals negative for anti-hepatitis B core antibody. Medicine (Baltimore) 2016;95:e5625. [PMID: 27930595 DOI: 10.1097/MD.0000000000005625] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
47 Dodd RY. Current risk for transfusion transmitted infections. Curr Opin Hematol 2007;14:671-6. [PMID: 17898573 DOI: 10.1097/MOH.0b013e3282e38e8a] [Cited by in Crossref: 1] [Cited by in F6Publishing: 25] [Article Influence: 0.1] [Reference Citation Analysis]
48 Reaiche GY, Le Mire MF, Mason WS, Jilbert AR. The persistence in the liver of residual duck hepatitis B virus covalently closed circular DNA is not dependent upon new viral DNA synthesis. Virology. 2010;406:286-292. [PMID: 20705309 DOI: 10.1016/j.virol.2010.07.013] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
49 Nebbia G, Garcia-Diaz A, Ayliffe U, Smith C, Dervisevic S, Johnson M, Gilson R, Tedder R, Geretti AM. Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons. J Med Virol. 2007;79:1464-1471. [PMID: 17705185 DOI: 10.1002/jmv.20954] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 2.5] [Reference Citation Analysis]
50 Chen DS. Toward elimination and eradication of hepatitis B. J Gastroenterol Hepatol. 2010;25:19-25. [PMID: 20136972 DOI: 10.1111/j.1440-1746.2009.06165.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 4.7] [Reference Citation Analysis]
51 Laperche S, Thibault V, Bouchardeau F, Alain S, Castelain S, Gassin M, Gueudin M, Halfon P, Larrat S, Lunel F, Martinot-Peignoux M, Mercier B, Pawlotsky JM, Pozzetto B, Roque-Afonso AM, Roudot-Thoraval F, Sauné K, Lefrère JJ. Expertise of laboratories in viral load quantification, genotyping, and precore mutant determination for hepatitis B virus in a multicenter study. J Clin Microbiol 2006;44:3600-7. [PMID: 17021089 DOI: 10.1128/JCM.00732-06] [Cited by in Crossref: 25] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
52 Prati D, Gerosa A, Porretti L. Occult HBV infection and blood transfusion. J Hepatol. 2006;44:818; author reply 819. [PMID: 16473431 DOI: 10.1016/j.jhep.2005.12.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
53 Ryan K, Anderson M, Gyurova I, Ambroggio L, Moyo S, Sebunya T, Makhema J, Marlink R, Essex M, Musonda R, Gaseitsiwe S, Blackard JT. High Rates of Occult Hepatitis B Virus Infection in HIV-Positive Individuals Initiating Antiretroviral Therapy in Botswana. Open Forum Infect Dis 2017;4:ofx195. [PMID: 29062862 DOI: 10.1093/ofid/ofx195] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
54 Fonseca JC. Natural history of chronic hepatitis B. Rev Soc Bras Med Trop. 2007;40:672-677. [PMID: 18200423 DOI: 10.1590/S0037-86822007000600015] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
55 Kupek E, Petry A. Comparison of epidemiological methods for estimation of hepatitis B incidence and residual risk for blood donors in southern Brazil. J Transfus 2011;2011:985383. [PMID: 25346858 DOI: 10.4061/2011/985383] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
56 Shire NJ, Rouster SD, Stanford SD, Blackard JT, Martin CM, Fichtenbaum CJ, Sherman KE. The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients. J Acquir Immune Defic Syndr. 2007;44:309-314. [PMID: 17159656 DOI: 10.1097/qai.0b013e31802e29a9] [Cited by in Crossref: 51] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
57 Vaezjalali M, Rashidpour S, Rezaee H, Hajibeigi B, Zeidi M, Gachkar L, Aghamohamad S, Najafi R, Goudarzi H. Hepatitis B viral DNA among HBs antigen negative healthy blood donors. Hepat Mon. 2013;13:e6590. [PMID: 23675384 DOI: 10.5812/hepatmon.6590] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
58 Su TH, Chen PJ. Emerging hepatitis B virus infection in vaccinated populations: a rising concern? Emerg Microbes Infect 2012;1:e27. [PMID: 26038431 DOI: 10.1038/emi.2012.28] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
59 Escobedo-Melendez G, Panduro A, Fierro NA, Roman S. High prevalence of occult hepatitis B virus genotype H infection among children with clinical hepatitis in west Mexico. Mem Inst Oswaldo Cruz 2014;109:728-37. [PMID: 25099333 DOI: 10.1590/0074-0276140058] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
60 Raimondo G, Pollicino T, Cacciola I, Squadrito G. Occult hepatitis B virus infection. J Hepatol. 2007;46:160-170. [PMID: 17112622 DOI: 10.1016/j.jhep.2006.10.007] [Cited by in Crossref: 335] [Cited by in F6Publishing: 326] [Article Influence: 22.3] [Reference Citation Analysis]
61 Kim H, Hur M, Moon HW, Park CM, Cho JH, Park KS, Lee K, Chang S. Pre- and post-transfusion testing for hepatitis B virus surface antigen and antibody in blood recipients: a single-institution experience in an area of high endemicity. Ann Lab Med. 2012;32:73-78. [PMID: 22259782 DOI: 10.3343/alm.2012.32.1.73] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
62 Rao W, Xie M, Yang T, Zhang JJ, Gao W, Deng YL, Zheng H, Pan C, Liu YH, Shen ZY. Risk factors for de novo hepatitis B infection in pediatric living donor liver transplantation. World J Gastroenterol 2014; 20(36): 13159-13166 [PMID: 25278711 DOI: 10.3748/wjg.v20.i36.13159] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
63 Li L, Chen PJ, Chen MH, Chak KF, Lin KS, Tsai SJ. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus. Transfusion 2008;48:1198-206. [PMID: 18422856 DOI: 10.1111/j.1537-2995.2008.01672.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 3.2] [Reference Citation Analysis]
64 Arababadi MK, Hassanshahi G, Pourfathollah AA, Zarandi ER, Kennedy D. Post-Transfusion Occult Hepatitis B (OBI): A Global Challenge for Blood Recipients and Health Authorities. Hepat Mon 2011;11:714-8. [DOI: 10.5812/kowsar.1735143x.505] [Cited by in Crossref: 7] [Article Influence: 0.7] [Reference Citation Analysis]
65 Michalak TI, Pham TN, Mulrooney-cousins PM. Molecular diagnosis of occult HCV and HBV infections. Future Virology 2007;2:451-65. [DOI: 10.2217/17460794.2.5.451] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
66 Olagbenro M, Anderson M, Gaseitsiwe S, Powell EA, Gededzha MP, Selabe SG, Blackard JT. In silico analysis of mutations associated with occult hepatitis B virus (HBV) infection in South Africa. Arch Virol 2021;166:3075-84. [PMID: 34468889 DOI: 10.1007/s00705-021-05196-7] [Reference Citation Analysis]
67 Seo DH, Whang DH, Song EY, Kim HS, Park Q. Prevalence of antibodies to hepatitis B core antigen and occult hepatitis B virus infections in Korean blood donors. Transfusion. 2011;51:1840-1846. [PMID: 21332731 DOI: 10.1111/j.1537-2995.2010.03056.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 4.0] [Reference Citation Analysis]
68 Vermeulen M, Dickens C, Lelie N, Walker E, Coleman C, Keyter M, Reddy R, Crookes R, Kramvis A. Hepatitis B virus transmission by blood transfusion during 4 years of individual-donation nucleic acid testing in South Africa: estimated and observed window period risk. Transfusion. 2012;52:880-892. [PMID: 21981386 DOI: 10.1111/j.1537-2995.2011.03355.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 5.2] [Reference Citation Analysis]
69 Lai MW, Lin TY, Tsao KC, Huang CG, Hsiao MJ, Liang KH, Yeh CT. Increased seroprevalence of HBV DNA with mutations in the s gene among individuals greater than 18 years old after complete vaccination. Gastroenterology. 2012;143:400-407. [PMID: 22580098 DOI: 10.1053/j.gastro.2012.05.002] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 5.6] [Reference Citation Analysis]
70 El-Sayed MH, Said ZNA, Abo-Elmagd EK, Ebeid FSE, Salama II. High Risk of HBV Infection Among Vaccinated Polytransfused Children With Malignancy. J Pediatr Hematol Oncol 2021;43:e45-50. [PMID: 32769568 DOI: 10.1097/MPH.0000000000001887] [Reference Citation Analysis]
71 Yuen M, Ka-ho Wong D, Lee C, Tanaka Y, Allain J, Fung J, Leung J, Lin C, Sugiyama M, Sugauchi F, Mizokami M, Lai C. Transmissibility of Hepatitis B Virus (HBV) Infection through Blood Transfusion from Blood Donors with Occult HBV Infection. Clinical Infectious Diseases 2011;52:624-32. [DOI: 10.1093/cid/ciq247] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 5.3] [Reference Citation Analysis]
72 Fuente RAL, Gutiérrez ML, Garcia-Samaniego J, Fernández-Rodriguez C, Lledó JL, Castellano G. Pathogenesis of occult chronic hepatitis B virus infection. World J Gastroenterol 2011; 17(12): 1543-1548 [PMID: 21472118 DOI: 10.3748/wjg.v17.i12.1543] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
73 Javanmard D, Namaei MH, Farahmand M, Ziaee A, Amini E, Ziaee M. Molecular and serological characterization of occult hepatitis B virus infection among patients with hemophilia. J Med Virol 2019;91:1519-27. [PMID: 30908666 DOI: 10.1002/jmv.25470] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
74 Rouphael NG, Talati NJ, Rimland D. Hepatitis B reverse seroconversion in HIV-positive patients: case series and review of the literature. AIDS. 2007;21:771-774. [PMID: 17413702 DOI: 10.1097/qad.0b013e3280ad47f5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
75 Aghasadeghi MR, Velayati AA, Mamishi S, Nabavi M, Aghakhani A, Bidari-Zerehpoosh F, Haghi Ashtiani MT, Sabeti S, Banifazl M, Azimian-Zavareh F, Motevalli F, Soleymani S, Ramezani A. Low prevalence of hepatitis B vaccine escape mutants among individuals born after the initiation of a nationwide vaccination program in Iran. Arch Virol 2016;161:3405-11. [PMID: 27613286 DOI: 10.1007/s00705-016-3050-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
76 Valsamakis A. Molecular testing in the diagnosis and management of chronic hepatitis B. Clin Microbiol Rev. 2007;20:426-439, table of contents. [PMID: 17630333 DOI: 10.1128/cmr.00009-07] [Cited by in Crossref: 86] [Cited by in F6Publishing: 32] [Article Influence: 6.1] [Reference Citation Analysis]